Jennifer Stevens serves as Executive at TriSalus Life Sciences, Inc., where they oversee executive responsibilities. Since joining the company, Jennifer Stevens has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 24, 2025 involved receiving (via award) 50,000 shares valued at $0.
Jennifer Stevens currently holds 127,640 shares of TriSalus Life Sciences, Inc. (TLSI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jennifer Stevens has been a net neutral trader of TLSI stock. They have purchased $0 and sold $0 worth of shares.
Jennifer Stevens's most recent insider trade was on Nov 24, 2025, when they sold 50,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |